Eidos Therapeutics, Inc.

Historical 13F Holders

Symbol
EIDX
CUSIP
98422L107
All holders as of
Q2 2022
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q2 1 803 $1.00 k
2022 Q1 2 70.8 k $181 k
2021 Q4 1 803 $2.00 k
2021 Q3 78 16.8 M $41.2 M
2021 Q2 107 28.2 M $115 M
2021 Q1 112 33.2 M $150 M
2020 Q4 113 25.8 M $127 M
2020 Q3 98 25.3 M $150 M
2020 Q2 88 32.1 M $85.3 M
2020 Q1 71 23.5 M $45.8 M
2019 Q4 58 18.0 M $130 M
2019 Q3 55 17.9 M $176 M
2019 Q2 52 16.9 M $193 M
2019 Q1 52 16.0 M $161 M
2018 Q4 37 10.9 M $185 M
2018 Q3 38 10.5 M $186 M
2018 Q2 31 9.72 M $184 M